Sg Americas Securities, LLC Brainstorm Cell Therapeutics Inc. Transaction History

Sg Americas Securities, LLC

  • $24.4 Billion
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 13, 2021
SELL
$3.46 - $7.88 $51,830 - $118,042
-14,980 Closed
0 $0
Q4 2020

Feb 04, 2021
SELL
$3.99 - $17.73 $338,882 - $1.51 Million
-84,933 Reduced 85.01%
14,980 $68,000
Q3 2020

Nov 09, 2020
BUY
$11.19 - $16.92 $979,427 - $1.48 Million
87,527 Added 706.66%
99,913 $1.69 Million
Q2 2020

Jul 20, 2020
BUY
$4.42 - $12.66 $54,746 - $156,806
12,386 New
12,386 $139,000

Others Institutions Holding BCLI

# of Institutions
33
Shares Held
10.5M
Call Options Held
160K
Put Options Held
30.5K
View Full List

About BRAINSTORM CELL THERAPEUTICS INC.

BCLI Quotes by TradingView
  • Ticker BCLI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,486,200
  • Market Cap $69.3M
  • Description
  • Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem ...
More about BCLI
Track This Portfolio

Track Sg Americas Securities, LLC Portfolio

Follow Sg Americas Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email